Search

everythinglearnresearchcommunity

for

Search:↓

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Syphilis can cause unusual symptoms like hair loss and joint pain, but treatment is effective.

Hormonal therapies effectively treat acne and improve quality of life.

Clascoterone cream effectively reduces acne severity and is safe for patients 12 and older.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

Topical metformin shows promise for dental and skin treatments, including periodontitis, hair regrowth, wound healing, and acne.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

The CuCS/Cur wound dressing helps regenerate nerves and heal deep skin burns by rebuilding hair follicles.

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Some skin medication can rarely cause or worsen mental health issues; knowing this is important because mental health problems are increasing worldwide.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

Activin A and follistatin control when ear hair cells form in mice.

Activin A promotes ear hair cell development, while follistatin delays it.